Neonc Technologies Holdings (NTHI) Interest Coverage Ratio (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Interest Coverage Ratio of 7.18 for Q1 2026, up 93.05% year-over-year from 3.72 in Q1 2025, and up 33.05% quarter-over-quarter from 10.73 in Q4 2025.
Neonc Technologies Holdings (NTHI) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Interest Coverage Ratio for 3 consecutive years, with 7.18 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 93.05% year-over-year to 7.18; the TTM figure through Mar 2026 stood at 9.71 (up 61.7% YoY), while the FY2025 annual figure was 1.89, down 260.49% from the prior year.
- Interest Coverage Ratio grew to 7.18 in Q1 2026 per NTHI's latest filing, from 10.73 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 880.35 in Q4 2024 and bottomed at 103.27 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 85.78 across 3 years, with a median of 7.58 in 2025.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio tumbled 9135.0% — and 2026, when it soared 93.05%.
- Neonc Technologies Holdings' Interest Coverage Ratio stood at 880.35 in 2024, then plunged by 101.22% to 10.73 in 2025, then jumped by 33.05% to 7.18 in 2026.
- Business Quant data shows NTHI's Interest Coverage Ratio at 7.18 in Q1 2026, 10.73 in Q4 2025, and 7.97 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -60.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39.47 |
| Mar 31, 2026 | -7.18 |
| Dec 31, 2025 | -10.73 |
| Sep 30, 2025 | -7.97 |
| Jun 30, 2025 | -62.78 |
| Mar 31, 2025 | -103.27 |
| Dec 31, 2024 | 880.35 |
| Jun 30, 2024 | -1.09 |
| Mar 31, 2024 | -1.12 |